Joincare Pharmaceutical Group Industry Co Ltd (600380) — Capital Reinvestment Ratio
Joincare Pharmaceutical Group Industry Co Ltd (600380) has a Capital Reinvestment Ratio of 0.14x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥1.09 Billion) in capital expenditures (CN¥155.85 Million). Check Joincare Pharmaceutical Group Industry C tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Joincare Pharmaceutical Group Industry Co Ltd Capital Reinvestment Ratio (1999–2025)
This chart tracks Joincare Pharmaceutical Group Industry Co Ltd's Capital Reinvestment Ratio across 27 annual periods. For the full cash flow conversion analysis, see Joincare Pharmaceutical Group Industry C (600380) cash conversion ratio.
Annual Capital Reinvestment Ratio for Joincare Pharmaceutical Group Industry Co Ltd (1999–2025)
Year-by-year Capital Reinvestment Ratio for Joincare Pharmaceutical Group Industry Co Ltd from 1999 to 2025. See cash generation quality of Joincare Pharmaceutical Group Industry C to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.20x | CN¥3.89 Billion | CN¥767.20 Million | ▼ -26.8% |
| 2024 | 0.27x | CN¥3.64 Billion | CN¥979.13 Million | ▼ -6.4% |
| 2023 | 0.29x | CN¥3.93 Billion | CN¥1.13 Billion | ▼ -0.3% |
| 2022 | 0.29x | CN¥3.98 Billion | CN¥1.15 Billion | ▼ -51.4% |
| 2021 | 0.59x | CN¥2.56 Billion | CN¥1.52 Billion | ▲ +116.2% |
| 2020 | 0.27x | CN¥3.02 Billion | CN¥830.41 Million | ▼ -9.7% |
| 2019 | 0.30x | CN¥2.31 Billion | CN¥703.20 Million | ▼ -15.2% |
| 2018 | 0.36x | CN¥1.83 Billion | CN¥655.02 Million | ▲ +39.6% |
| 2017 | 0.26x | CN¥1.87 Billion | CN¥480.68 Million | ▼ -15.5% |
| 2016 | 0.30x | CN¥1.64 Billion | CN¥499.99 Million | ▼ -35.3% |
| 2015 | 0.47x | CN¥1.26 Billion | CN¥594.33 Million | ▼ -43.7% |
| 2014 | 0.83x | CN¥979.46 Million | CN¥816.97 Million | ▼ -46.1% |
| 2013 | 1.55x | CN¥635.52 Million | CN¥983.83 Million | ▲ +31.7% |
| 2012 | 1.18x | CN¥734.36 Million | CN¥863.48 Million | ▲ +73.8% |
| 2011 | 0.68x | CN¥650.36 Million | CN¥440.12 Million | ▲ +28.0% |
| 2010 | 0.53x | CN¥1.11 Billion | CN¥584.47 Million | ▲ +4.4% |
| 2009 | 0.51x | CN¥605.66 Million | CN¥306.87 Million | ▲ +5.9% |
| 2008 | 0.48x | CN¥455.01 Million | CN¥217.71 Million | ▼ -16.7% |
| 2007 | 0.57x | CN¥429.26 Million | CN¥246.63 Million | ▼ -68.1% |
| 2006 | 1.80x | CN¥272.50 Million | CN¥490.19 Million | ▲ +77.6% |
| 2005 | 1.01x | CN¥363.13 Million | CN¥367.73 Million | ▲ +11.3% |
| 2004 | 0.91x | CN¥241.71 Million | CN¥219.90 Million | ▲ +41.7% |
| 2003 | 0.64x | CN¥172.25 Million | CN¥110.60 Million | ▲ +64.6% |
| 2002 | 0.39x | CN¥236.13 Million | CN¥92.09 Million | ▲ +25.5% |
| 2001 | 0.31x | CN¥223.79 Million | CN¥69.55 Million | ▼ -23.2% |
| 2000 | 0.40x | CN¥171.61 Million | CN¥69.46 Million | ▼ -9.6% |
| 1999 | 0.45x | CN¥109.82 Million | CN¥49.15 Million | — |